140 related articles for article (PubMed ID: 23025533)
21. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes.
Berndt SI; Vijai J; Benavente Y; Camp NJ; Nieters A; Wang Z; Smedby KE; Kleinstern G; Hjalgrim H; Besson C; Skibola CF; Morton LM; Brooks-Wilson AR; Teras LR; Breeze C; Arias J; Adami HO; Albanes D; Anderson KC; Ansell SM; Bassig B; Becker N; Bhatti P; Birmann BM; Boffetta P; Bracci PM; Brennan P; Brown EE; Burdett L; Cannon-Albright LA; Chang ET; Chiu BCH; Chung CC; Clavel J; Cocco P; Colditz G; Conde L; Conti DV; Cox DG; Curtin K; Casabonne D; De Vivo I; Diepstra A; Diver WR; Dogan A; Edlund CK; Foretova L; Fraumeni JF; Gabbas A; Ghesquières H; Giles GG; Glaser S; Glenn M; Glimelius B; Gu J; Habermann TM; Haiman CA; Haioun C; Hofmann JN; Holford TR; Holly EA; Hutchinson A; Izhar A; Jackson RD; Jarrett RF; Kaaks R; Kane E; Kolonel LN; Kong Y; Kraft P; Kricker A; Lake A; Lan Q; Lawrence C; Li D; Liebow M; Link BK; Magnani C; Maynadie M; McKay J; Melbye M; Miligi L; Milne RL; Molina TJ; Monnereau A; Montalvan R; North KE; Novak AJ; Onel K; Purdue MP; Rand KA; Riboli E; Riby J; Roman E; Salles G; Sborov DW; Severson RK; Shanafelt TD; Smith MT; Smith A; Song KW; Song L; Southey MC; Spinelli JJ; Staines A; Stephens D; Sutherland HJ; Tkachuk K; Thompson CA; Tilly H; Tinker LF; Travis RC; Turner J; Vachon CM; Vajdic CM; Van Den Berg A; Van Den Berg DJ; Vermeulen RCH; Vineis P; Wang SS; Weiderpass E; Weiner GJ; Weinstein S; Doo NW; Ye Y; Yeager M; Yu K; Zeleniuch-Jacquotte A; Zhang Y; Zheng T; Ziv E; Sampson J; Chatterjee N; Offit K; Cozen W; Wu X; Cerhan JR; Chanock SJ; Slager SL; Rothman N
Leukemia; 2022 Dec; 36(12):2835-2844. PubMed ID: 36273105
[TBL] [Abstract][Full Text] [Related]
22. GWAS of follicular lymphoma reveals allelic heterogeneity at 6p21.32 and suggests shared genetic susceptibility with diffuse large B-cell lymphoma.
Smedby KE; Foo JN; Skibola CF; Darabi H; Conde L; Hjalgrim H; Kumar V; Chang ET; Rothman N; Cerhan JR; Brooks-Wilson AR; Rehnberg E; Irwan ID; Ryder LP; Brown PN; Bracci PM; Agana L; Riby J; Cozen W; Davis S; Hartge P; Morton LM; Severson RK; Wang SS; Slager SL; Fredericksen ZS; Novak AJ; Kay NE; Habermann TM; Armstrong B; Kricker A; Milliken S; Purdue MP; Vajdic CM; Boyle P; Lan Q; Zahm SH; Zhang Y; Zheng T; Leach S; Spinelli JJ; Smith MT; Chanock SJ; Padyukov L; Alfredsson L; Klareskog L; Glimelius B; Melbye M; Liu ET; Adami HO; Humphreys K; Liu J
PLoS Genet; 2011 Apr; 7(4):e1001378. PubMed ID: 21533074
[TBL] [Abstract][Full Text] [Related]
23. Fine-scale mapping of the 6p25.3 chronic lymphocytic leukaemia susceptibility locus.
Crowther-Swanepoel D; Broderick P; Ma Y; Robertson L; Pittman AM; Price A; Twiss P; Vijayakrishnan J; Qureshi M; Dyer MJ; Matutes E; Dearden C; Catovsky D; Houlston RS
Hum Mol Genet; 2010 May; 19(9):1840-5. PubMed ID: 20123861
[TBL] [Abstract][Full Text] [Related]
24. bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia.
Hanada M; Delia D; Aiello A; Stadtmauer E; Reed JC
Blood; 1993 Sep; 82(6):1820-8. PubMed ID: 8104532
[TBL] [Abstract][Full Text] [Related]
25. Association of bcl-1 rearrangements with lymphocytic lymphoma of intermediate differentiation.
Medeiros LJ; Van Krieken JH; Jaffe ES; Raffeld M
Blood; 1990 Nov; 76(10):2086-90. PubMed ID: 2242428
[TBL] [Abstract][Full Text] [Related]
26. Hormone replacement therapy and risk of non-hodgkin lymphoma and chronic lymphocytic leukemia.
Cerhan JR; Vachon CM; Habermann TM; Ansell SM; Witzig TE; Kurtin PJ; Janney CA; Zheng W; Potter JD; Sellers TA; Folsom AR
Cancer Epidemiol Biomarkers Prev; 2002 Nov; 11(11):1466-71. PubMed ID: 12433728
[TBL] [Abstract][Full Text] [Related]
27. Increased expression of the hPim-2 gene in human chronic lymphocytic leukemia and non-Hodgkin lymphoma.
Cohen AM; Grinblat B; Bessler H; Kristt D; Kremer A; Schwartz A; Halperin M; Shalom S; Merkel D; Don J
Leuk Lymphoma; 2004 May; 45(5):951-5. PubMed ID: 15291354
[TBL] [Abstract][Full Text] [Related]
28. rs2072135, a low-penetrance variant for chronic lymphocytic leukaemia?
Sava GP; Speedy HE; Di Bernardo MC; Deaglio S; Karabon L; Frydecka I; Woszczyk D; Rossi D; Gaidano G; Mansouri L; Smedby KE; Juliusson G; Rosenquist R; Catovsky D; Houlston RS
Br J Haematol; 2013 Jul; 162(2):221-8. PubMed ID: 23668599
[TBL] [Abstract][Full Text] [Related]
29. PRRC2A and BCL2L11 gene variants influence risk of non-Hodgkin lymphoma: results from the InterLymph consortium.
Nieters A; Conde L; Slager SL; Brooks-Wilson A; Morton L; Skibola DR; Novak AJ; Riby J; Ansell SM; Halperin E; Shanafelt TD; Agana L; Wang AH; De Roos AJ; Severson RK; Cozen W; Spinelli J; Butterbach K; Becker N; de Sanjose S; Benavente Y; Cocco P; Staines A; Maynadié M; Foretova L; Boffetta P; Brennan P; Lan Q; Zhang Y; Zheng T; Purdue M; Armstrong B; Kricker A; Vajdic CM; Grulich A; Smith MT; Bracci PM; Chanock SJ; Hartge P; Cerhan JR; Wang SS; Rothman N; Skibola CF
Blood; 2012 Nov; 120(23):4645-8. PubMed ID: 23047821
[TBL] [Abstract][Full Text] [Related]
30. Molecular pathways in low grade B-cell lymphoma.
Gaidano G; Pastore C; Capello D; Cilli V; Saglio G
Leuk Lymphoma; 1997 Dec; 26 Suppl 1():107-13. PubMed ID: 9570687
[TBL] [Abstract][Full Text] [Related]
31. Increased metastasis of malignant fibrous histiocytoma in patients with chronic lymphocytic leukemia and non-hodgkin lymphoma.
Kubica AW; Rose PS; Weaver AL; Brewer JD
Mayo Clin Proc; 2011 Aug; 86(8):738-43. PubMed ID: 21803956
[TBL] [Abstract][Full Text] [Related]
32. Human leukocyte antigen class I and II alleles in non-Hodgkin lymphoma etiology.
Wang SS; Abdou AM; Morton LM; Thomas R; Cerhan JR; Gao X; Cozen W; Rothman N; Davis S; Severson RK; Bernstein L; Hartge P; Carrington M
Blood; 2010 Jun; 115(23):4820-3. PubMed ID: 20385791
[TBL] [Abstract][Full Text] [Related]
33. Genetic variants at 6p21.33 are associated with susceptibility to follicular lymphoma.
Skibola CF; Bracci PM; Halperin E; Conde L; Craig DW; Agana L; Iyadurai K; Becker N; Brooks-Wilson A; Curry JD; Spinelli JJ; Holly EA; Riby J; Zhang L; Nieters A; Smith MT; Brown KM
Nat Genet; 2009 Aug; 41(8):873-5. PubMed ID: 19620980
[TBL] [Abstract][Full Text] [Related]
34. Risk of cutaneous T-cell lymphoma in patients with chronic lymphocytic leukemia and other subtypes of non-Hodgkin lymphoma.
Chang TW; Weaver AL; Shanafelt TD; Habermann TM; Wriston CC; Cerhan JR; Call TG; Brewer JD
Int J Dermatol; 2017 Nov; 56(11):1125-1129. PubMed ID: 28685851
[TBL] [Abstract][Full Text] [Related]
35. Chromosomal translocation t(14;19) as indicated by bcl-3 rearrangement is a rare phenomenon in non-Hodgkin's lymphoma and chronic lymphocytic leukemia: a molecular genetic analysis of 176 cases.
van Krieken JH; McKeithan TW; Raghoebier S; Medeiros LJ; Kluin PM; Raffeld M
Leukemia; 1990 Dec; 4(12):811-2. PubMed ID: 2243504
[TBL] [Abstract][Full Text] [Related]
36. HLA Class I and II Diversity Contributes to the Etiologic Heterogeneity of Non-Hodgkin Lymphoma Subtypes.
Wang SS; Carrington M; Berndt SI; Slager SL; Bracci PM; Voutsinas J; Cerhan JR; Smedby KE; Hjalgrim H; Vijai J; Morton LM; Vermeulen R; Paltiel O; Vajdic CM; Linet MS; Nieters A; de Sanjose S; Cozen W; Brown EE; Turner J; Spinelli JJ; Zheng T; Birmann BM; Flowers CR; Becker N; Holly EA; Kane E; Weisenburger D; Maynadie M; Cocco P; Albanes D; Weinstein SJ; Teras LR; Diver WR; Lax SJ; Travis RC; Kaaks R; Riboli E; Benavente Y; Brennan P; McKay J; Delfau-Larue MH; Link BK; Magnani C; Ennas MG; Latte G; Feldman AL; Doo NW; Giles GG; Southey MC; Milne RL; Offit K; Musinsky J; Arslan AA; Purdue MP; Adami HO; Melbye M; Glimelius B; Conde L; Camp NJ; Glenn M; Curtin K; Clavel J; Monnereau A; Cox DG; Ghesquières H; Salles G; Bofetta P; Foretova L; Staines A; Davis S; Severson RK; Lan Q; Brooks-Wilson A; Smith MT; Roman E; Kricker A; Zhang Y; Kraft P; Chanock SJ; Rothman N; Hartge P; Skibola CF
Cancer Res; 2018 Jul; 78(14):4086-4096. PubMed ID: 29735552
[TBL] [Abstract][Full Text] [Related]
37. Richter's syndrome with identical immunoglobulin gene rearrangements in the chronic lymphocytic leukemia and the supervening non-Hodgkin lymphoma.
Michiels JJ; van Dongen JJ; Hagemeijer A; Sonneveld P; Ploemacher RE; Adriaansen HJ; van der Kwast TH; Brederoo P; Abels J
Leukemia; 1989 Nov; 3(11):819-24. PubMed ID: 2811481
[TBL] [Abstract][Full Text] [Related]
38. Rearrangement of the chromosome 11 bcl-1 locus in centrocytic lymphoma: analysis with multiple breakpoint probes.
Williams ME; Meeker TC; Swerdlow SH
Blood; 1991 Jul; 78(2):493-8. PubMed ID: 2070085
[TBL] [Abstract][Full Text] [Related]
39. Familial risk for non-Hodgkin lymphoma and other lymphoproliferative malignancies by histopathologic subtype: the Swedish Family-Cancer Database.
Altieri A; Bermejo JL; Hemminki K
Blood; 2005 Jul; 106(2):668-72. PubMed ID: 15811955
[TBL] [Abstract][Full Text] [Related]
40. Fcγ receptor polymorphisms and clinical efficacy of rituximab in non-Hodgkin lymphoma and chronic lymphocytic leukemia.
Zhuang Y; Xu W; Shen Y; Li J
Clin Lymphoma Myeloma Leuk; 2010 Oct; 10(5):347-52. PubMed ID: 21030347
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
